Nice | Apixaban for the treatment of DVT and PE

27th July 2015 by Louise Hudman

Nice | Apixaban for the treatment of DVT and PE

This is a new guideline from Nice on apixaban. It has now been approved for the treatment of and secondary prevention of DVT and VTE.

Now dabigatran, rivaroxaban and apixaban can all be used in AF, for the prevention of VTE after hip surgery and for treatment and secondary prevention of DVT and PE.

Join

Join to view the rest of this content, as well as access all the benefits of joining NASGP.

Join

Login

Already a member? Login to view this content.

Login

"LocumDeck really is brilliant. I've always relied on my own system - I never put my faith in any other system before LocumDeck.

But I was genuinely buzzing when I used it yesterday - how easy it was to use and how many other things it does. It will significantly change and improve my invoicing and end of the month. "

Dr Kathryn Furneaux

See the full list of features within our NASGP membership plans

Membership